COST ASSESSMENT AND EXAMPLE APPROACH TO DEEP VENOUS THROMBOSIS TREATMENT

Summary The authors provide an overview of the social significance of the deep venous thrombosis (DVT) and large funds from both patients and health insurance organisations for the treatment. We compared the results obtained during treatment of patients with unfractionated heparin (UFH) and low molecular weight heparin (LMWH). The presented data and results for the cost of treatment of DVT patients require considerable financing. From the economic point of view under the conditions of health insurance it is important to increase the number of patients treated in outpatient settings.